Assyro AI

Orange Book product · Generic (ANDA)

RIFAMPIN

RIFAMPIN

Generic (ANDA)ANDA 065028DISCN HIKMA
View RIFAMPIN familyOpen on FDA Orange Book

At a glance

Mar 14, 2001

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 14, 2001

    25 yr 8 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

RIFAMPIN

Strength

150MG

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

ANDA 065028

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of RIFAMPIN

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo